SCHEMBL17627311

SCHEMBL17627311

[CH2]n1cc(Oc2cc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC(C)(C)CC4)CC3)ccc2C(=O)NSc2ccc(OCC3(F)CCOCC3)c([N+](=O)[O-])c2)cc2ccnc1-2

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 14/20 0.64
▸ BCL2L1 Q07817 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17627306 0.91 BCL2 (0.78) BCL2
SCHEMBL524049 0.83 BCL2 (0.75) BCL2
SCHEMBL21291488 0.81 BCL2 (0.72) BCL2BCL2L1
SCHEMBL17627321 0.79 BCL2 (0.82) BCL2BCL2L1
SCHEMBL1956292 0.79 BCL2 (0.91) BCL2
SCHEMBL19940459 0.79 BCL2 (0.63) BCL2BCL2L1
SCHEMBL1957560 0.78 BCL2 (1.00) BCL2
SCHEMBL1955671 0.78 BCL2 (0.83) BCL2
SCHEMBL30313804 0.78 BCL2 (0.91) BCL2BCL2L1
SCHEMBL523310 0.78 BCL2 (0.91) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2575463-B1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC (US) 2016-03-30 — — EP claimed
Send feedback